Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/article/10.1245/s10434-017-6014-0/fulltext.html
Reference38 articles.
1. Platt J, Baxter N, Zhong T. Breast reconstruction after mastectomy for breast cancer. CMAJ Can Med Assoc J. 2011;183:2109–16.
2. Zhong T, Hu J, Bagher S, et al. A comparison of psychological response, body image, sexuality, and quality of life between immediate and delayed autologous tissue breast reconstruction: a prospective long-term outcome study. Plast Reconstr Surg. 2016;138:772–80.
3. Zhong T, McCarthy C, Min S, et al. Patient satisfaction and health-related quality of life after autologous tissue breast reconstruction: a prospective analysis of early postoperative outcomes. Cancer. 2012;118:1701–9.
4. Chao AH, Garza R III, Povoski SP. A review of the use of silicone implants in breast surgery. Exp Rev Med Dev. 2016;13:143–56.
5. Albornoz CR, Bach PB, Mehrara BJ, et al. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013;131:15–23.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL);Current Breast Cancer Reports;2024-06-25
2. Impact of the withdrawal of macrotextured implant on reconstruction practices;Bulletin du Cancer;2023-12
3. Impact of implant surface type on breast cancer relapse after breast reconstruction: propensity score-matched study;British Journal of Surgery;2023-06-12
4. Current Understanding of Breast Implant-Associated Anaplastic Large Cell Lymphoma;Cureus;2022-10-20
5. Enhanced Recovery Pathway Reduces Hospital Stay and Opioid Use in Microsurgical Breast Reconstruction: A Single-Center, Private Practice Experience;Plastic & Reconstructive Surgery;2022-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3